Protective role of heme oxygenase-1 in fatty liver ischemia–reperfusion injury
Authors:
Open Access
- 31 August 2018
- journal article
- review article
- Published by Springer Nature in Medical Molecular Morphology
- Vol. 52 (2) , 61-72
Abstract
Ischemia–reperfusion (IR) injury is a kind of injury resulting from the restoration of the blood supply after blood vessel closure during liver transplantation and is the main cause of graft failure. The pathophysiological mechanisms of hepatic IR include a variety of oxidative stress responses. Hepatic IR is characterized by ischemia and hypoxia inducing oxidative stress, immune response and apoptosis. Fat-denatured livers are also used as donors due to the lack of liver donors. Fatty liver is less tolerant to IR than normal liver. Heme oxygenase (HO) is an enzyme that breaks down hemoglobin to bilirubin, ferrous iron and carbon monoxide (CO). Inducible HO subtype HO-1 is an important protective molecule in mammalian cells used to improve acute and chronic liver injury owing to its characteristic anti-inflammatory and anti-apoptotic qualities. HO-1 degrades heme, and its reaction product CO has been shown to reduce hepatic IR injury and increase the survival rate of grafts. As an induced form of HO, HO-1 also exerts a protective effect against liver IR injury and may be useful as a new strategy of ameliorating this kind of damage. This review summarizes the protective effects of HO-1 in liver IR injury, especially in fatty liver.Keywords
Funding Information
- National Center for Child Health and Development
- Ministry of Education, Culture, Sports, Science and Technology of Japan
This publication has 118 references indexed in Scilit:
- Ischemia–reperfusion injury in rat steatotic liver is dependent on NFκB P65 activationTransplant Immunology, 2012
- Carbon Monoxide Induces Hypothermia Tolerance in Kupffer Cells and Attenuates Liver Ischemia/Reperfusion Injury in Rats†Liver Transplantation, 2011
- An apoptosis panel for nonalcoholic steatohepatitis diagnosisJournal of Hepatology, 2011
- Heme Oxygenase in the Regulation of Vascular Biology: From Molecular Mechanisms to Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2011
- Epigenetic Regulation of Insulin Resistance in Nonalcoholic Fatty Liver DiseaseHepatology, 2010
- Apoptosis and Cytokines in Non-Alcoholic SteatohepatitisClinics in Liver Disease, 2009
- Tissue-resident Macrophages Protect the Liver From Ischemia Reperfusion Injury via a Heme Oxygenase-1-Dependent MechanismMolecular Therapy, 2009
- Hepatocyte signaling through CXC chemokine receptor‐2 is detrimental to liver recovery after ischemia/reperfusion in mice†Hepatology, 2008
- Steatosis as a Risk Factor in Liver SurgeryAnnals of Surgery, 2007
- Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activationJournal of Experimental Medicine, 2006